The well-tempered vessel

被引:87
作者
Blau, HM [1 ]
Banfi, A [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA
关键词
D O I
10.1038/87850
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although gene therapy studies of angiogenesis have focused on the ability of endothelial cells to form new structures, it has recently become clear that the subsequent stages of remodeling are crucial to attaining stable and functional vessels. A precise balance of cell types and molecules is required for normal vessel maturation and must be considered in the design of therapeutic angiogenic strategies.
引用
收藏
页码:532 / 534
页数:3
相关论文
共 16 条
  • [1] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [2] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [3] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [4] Blood vessel maturation: Vascular development comes of age
    Darland, DC
    D'Amore, PA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 157 - 158
  • [5] Lee RJ, 2000, CIRCULATION, V102, P898
  • [6] PR39, a peptide regulator of angiogenesis
    Li, J
    Post, M
    Volk, R
    Gao, Y
    Li, M
    Metais, C
    Sato, K
    Tsai, J
    Aird, W
    Rosenberg, RD
    Hampton, TG
    Li, JY
    Sellke, F
    Carmeliet, P
    Simons, M
    [J]. NATURE MEDICINE, 2000, 6 (01) : 49 - 55
  • [7] Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
    Lindahl, P
    Johansson, BR
    Leveen, P
    Betsholtz, C
    [J]. SCIENCE, 1997, 277 (5323) : 242 - 245
  • [8] Angiogenesis gene therapy - Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
    Rosengart, TK
    Lee, LY
    Patel, SR
    Sanborn, TA
    Parikh, M
    Bergman, GW
    Hachamovitch, R
    Szulc, M
    Kligfield, PD
    Okin, PM
    Hahn, RT
    Devereux, RB
    Post, MR
    Hackett, NR
    Foster, T
    Grasso, TM
    Lesser, ML
    Isom, OW
    Crystal, RG
    [J]. CIRCULATION, 1999, 100 (05) : 468 - 474
  • [9] An address system in the vasculature of normal tissues and tumors
    Ruoslahti, E
    Rajotte, D
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 813 - 827
  • [10] Interindividual heterogeneity in the hypoxic regulation of VEGF - Significance for the development of the coronary artery collateral circulation
    Schultz, A
    Lavie, L
    Hochberg, I
    Beyar, R
    Stone, T
    Skorecki, K
    Lavie, P
    Roguin, A
    Levy, AP
    [J]. CIRCULATION, 1999, 100 (05) : 547 - 552